Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients

被引:1
|
作者
Nkondo-Ndaba, Maseqhala P. [1 ,2 ]
Joubert, Pierre M. [1 ,2 ]
Ballyram, Theona [1 ,2 ]
van Rensburg, Charl Janse [3 ]
机构
[1] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Psychiat, Pretoria, South Africa
[2] Weskoppies Psychiat Hosp, Pretoria, South Africa
[3] MRC, Biostat Unit, Pretoria, South Africa
关键词
psychiatric patients; antipsychotics; BMI; waist circumference; waist-to-hip ratio; waist-to-height ratio; body measures; SEVERE MENTAL-ILLNESS; CARDIOVASCULAR-DISEASE; HIP CIRCUMFERENCE; RISK-FACTORS; PREVALENCE; MORTALITY; SCHIZOPHRENIA; ASSOCIATION; OBESITY; IMPACT;
D O I
10.4102/sajpsychiatry.v28i0.1772
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The use of antipsychotic medication, particularly second generation antipsychotics (SGAs) is a major risk factor for cardiovascular disease in people with severe mental illness (SMI). Few studies have compared body measures of people with SMI taking first generation antipsychotics (FGAs) to those taking SGAs. Aim: We compare body measures between long-term male inpatients using either FGAs or SGAs. Setting: The study was conducted at Weskoppies Psychiatric Hospital, in Pretoria, Gauteng. Methods: A total of 30 patients were selected from a list of male inpatients and were included in our study. Each participant had the following anthropometric measures done and these were compared between the two groups: Waist circumference (WC), body mass index (BMI), waist to hip ratio (WHR), waist to height ratio (WHtR) and hip circumference (HC). Hospital records were used to record demographic variables, diagnosis, comorbid disease and psychotropic medication for each participant. Results: Participants in the FGA and SGA groups had similar body measures, resulting in similar BMI, WHR and WHtR. Participants had a mean HC of 100.5 cm, 95% confidence interval (CI) (97.68, 103.22). BMI ranged from 21.87 kg/m(2) to 37.65 kg/m(2), with an overall mean of 28.5 kg/m(2), 95% CI (26.69, 30.22). Participants had a mean WHtR of 0.59, 95% CI (0.56, 0.61). Participants had a mean WC of 100.6 cm and 95% CI (96.26, 104.87), and the mean WHR of both groups was 1.0. Conclusion: Participants using FGAs and SGAs had similar body measures, and these indicated that this sample of male inpatients with SMI is at high risk for CVD.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] A Tail with a Thorn in it: Second-Generation Antipsychotics Hand in Hand with Statins
    Durst, Ronen
    Leitersdorf, Eran
    CURRENT ATHEROSCLEROSIS REPORTS, 2012, 14 (05) : 391 - 393
  • [32] Weight Gain in Asian Patients on Second-generation Antipsychotics
    Mahendran, Rathi
    Hendricks, M.
    Chan, Yiong Huak
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 118 - 121
  • [33] Attitude towards second-generation antipsychotics among patients with schizophrenia and their relatives
    Karthik, M. S.
    Kulhara, Parmanand
    Chakrabarti, Subho
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 457 - 465
  • [34] The health status of first- and second-generation Turkish immigrants in Germany
    Wengler, Annelene
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2011, 56 (05) : 493 - 501
  • [35] Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
    Cernea, Simona
    Dima, Lorena
    Correll, Christoph U.
    Manu, Peter
    DRUGS, 2020, 80 (17) : 1763 - 1781
  • [36] Risks of Rheumatic Diseases in First- and Second-Generation Immigrants in Sweden
    Li, Xinjun
    Sundquist, Jan
    Sundquist, Kristina
    ARTHRITIS AND RHEUMATISM, 2009, 60 (06): : 1588 - 1596
  • [37] First- and second-generation antipsychotic medication and cognitive processing in schizophrenia
    Weickert T.W.
    Goldberg T.E.
    Current Psychiatry Reports, 2005, 7 (4) : 304 - 310
  • [38] Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain
    Vandenberghe, Frederik
    Najar-Giroud, Alexandra
    Holzer, Laurent
    Conus, Philippe
    Eap, Chin B.
    Ambresin, Anne-Emmanuelle
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (04) : 258 - 265
  • [39] Improvement of Metabolic Risk Profile Under Second-Generation Antipsychotics: A Pilot Intervention Study
    Blouin, Melissa
    Binet, Mario
    Bouchard, Roch-Hugo
    Roy, Marc-Andre
    Despres, Jean-Pierre
    Almeras, Natalie
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2009, 54 (04): : 275 - 279
  • [40] Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
    T Kishimoto
    V Agarwal
    T Kishi
    S Leucht
    J M Kane
    C U Correll
    Molecular Psychiatry, 2013, 18 : 53 - 66